ArticleJournal for immunotherapy of cancer2021

Pretreatment metastatic growth rate determines clinical outcome of advanced melanoma patients treated with anti-PD-1 antibodies: a multicenter cohort study.

Nikolaus B Wagner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.